Company History

Established in 2005 as Jiaxing Kaishi Biotechnology Co., Ltd, the Quaero Life Sciences Company has grown over the years into a powerhouse of production for IVD Instruments and related Consumables.

Quaero Life Sciences supports the development and production of in-vitro diagnostic instruments in various fields for a broad base of customers. With our research and development technology platform and lean manufacturing capabilities, we are able to customize streamlined processes according to the needs of in-vitro diagnostic manufacturers.

Since its establishment, Quaero Life Science has successfully developed more than 30 in-vitro diagnostic instrument products, covering major sub-segments of in-vitro diagnostics such as immunodiagnosis, biochemical diagnosis, microbiological diagnosis, pathological diagnosis, and POCT. As of June 30, 2022, the company and its subsidiaries have 131 domestic patents, including 27 invention patents.

Quaero Life Sciences is a major player in the Chinese market, serving many top manufacturers in the field of in-vitro diagnostics, including Chemclin Diagnostics, TransGen Biotech, Autobio, Zhonghanshengtai, AmoyDx, and Guangzhou Anbiping. In recent years, we have actively expanded our overseas market and brought our expertise in research, development, and production of in-vitro diagnostic instruments to the global market.

In the life science consumables field, Quaero has expertise in mold design and molding, production automation, material selection, and product application. We have independently developed a variety of consumable products such as tips, reaction cups (tubes), and containers, achieving efficient and high-quality mass production.

At the same time, Quaero has also increased research and development investment in areas such as cell therapy and microfluidics. In recent years, the company has rapidly developed in the field of life science consumables, and expanded collaboration with prominent in-vitro diagnostic and life science companies both domestically and internationally.

In terms of production and manufacturing, we have built a large-scale production base, with 23,000 square meters of factory space for the production of instruments and consumable products, and our new production base with over 1 million square feet of capacity will come online in 2024.